Since MCPyV-specific CD8+ and CD4+ T cells are found in MCC patients[28], the research of LT-specific immunotherapy is a logical step in generating an effective treatment for virus-induced cancer. This evidence concerns the gene CD4 and Merkel cell skin cancer.